Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
about
Opioids in pregnancy and neonatal abstinence syndromeTreating Women Who Are Pregnant and Parenting for Opioid Use Disorder and the Concurrent Care of Their Infants and Children: Literature Review to Support National GuidanceSafety of the newer class of opioid antagonists in pregnancy.The management of opioid dependence during pregnancy in rural and remote settingsGender Considerations in Addiction: Implications for Treatment.Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone.Case Presentations from the Addiction Academy.A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal OutcomesNeonatal abstinence syndrome: Pharmacologic strategies for the mother and infant.Observational study of the safety of buprenorphine+naloxone in pregnancy in a rural and remote populationNovel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth.Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations.Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?Pharmacological Management of Opioid Use Disorder in Pregnant Women.Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and GynecoSécurité de la plus récente classe d’antagonistes des opioïdes durant la grossesse.Prise en charge des troubles de consommation d’opioïdes en première ligne: Abstinence, méthadone ou buprénorphine-naloxone?Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.Suboxone: Rationale, Science, Misconceptions.Treating women with opioid use disorder during pregnancy in Appalachia: Initial neonatal outcomes following buprenorphine + naloxone exposure.Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence: Retrospective cohort study of 30 patients.
P2860
Q28082706-26D6C9DA-C053-4D5A-8425-F84054E270F8Q33760424-7C29145F-1308-4F15-8C22-037A319AD582Q33894730-EFDDE633-F688-4273-A303-303EC1DC87DBQ34825515-23DBB980-1F82-4B57-B8BF-F94AE41DB527Q36082618-50B8AD92-9843-4DDD-9D33-FB8B978D90FBQ36165912-76623F12-4305-4EB1-BB18-15C3F614C24DQ36660807-E1C507AF-8CE8-4726-9B91-348770C288FDQ36702592-9CEBA402-7B87-4A38-B1C3-FA0F400B7D87Q36730570-A2FBBA57-4ABE-4C56-A7C4-C00B17BDBB0FQ37390027-140475EA-3C34-43F0-9815-1CD866CC6807Q37397261-2954DC38-32E7-4EB3-88E3-AA6670B9D6CDQ37433241-55A49881-1207-43E5-A9D3-170334ECD64DQ37698941-A3199AEA-9CCF-4DE3-954C-5EDD0CC34A4EQ38575591-86CC957A-F9B6-4D95-AD98-2948AE7B721FQ39359619-32AF95DD-0392-4825-B93D-55A3E5926878Q45814246-24AFF885-2A1A-4E37-80BD-F6AF0BEAE7FDQ47122080-932B8C96-6D33-49ED-8F59-94844420C36CQ48901790-B32D552B-8470-4F9C-A90A-05B1D0F44C8EQ52645984-0F81CB0F-4817-43F8-BFDD-2E707C137CD7Q53081955-6B3A15FA-A3A1-4F75-B63C-1F14AE115978Q55058248-0E2D8B0C-6772-40C6-AF14-EAC20E0094CA
P2860
Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Buprenorphine + naloxone in th ...... patient care and outcome data.
@ast
Buprenorphine + naloxone in th ...... patient care and outcome data.
@en
type
label
Buprenorphine + naloxone in th ...... patient care and outcome data.
@ast
Buprenorphine + naloxone in th ...... patient care and outcome data.
@en
prefLabel
Buprenorphine + naloxone in th ...... patient care and outcome data.
@ast
Buprenorphine + naloxone in th ...... patient care and outcome data.
@en
P2093
P2860
P1476
Buprenorphine + naloxone in th ...... patient care and outcome data.
@en
P2093
Kevin E O'Grady
Kimber Debelak
William R Morrone
P2860
P304
P356
10.1111/J.1521-0391.2012.12005.X
P577
2013-05-01T00:00:00Z